Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by thacker786on Jan 27, 2020 7:57pm

126 Views

Post# 30605995

options 27 jan2020

Filed 2020-01-27 15:58 Tx date 2020-01-21	$SBM Sirona Biochem Corp.	Verrico, Howard Jarman 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$450,000 +1,000,000 vol $0.45 each	3,550,000
Filed 2020-01-27 15:51 Tx date 2020-01-21	$SBM Sirona Biochem Corp.	Deliencourt-Godefroy, Geraldine Annick Sylviane 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$450,000 +1,000,000 vol $0.45 each	1,500,000
Filed 2020-01-27 15:31 Tx date 2020-01-21	$SBM Sirona Biochem Corp.	Marazzi, Alex Sandro 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$45,000 +100,000 vol $0.45 each	100,000
Filed 2020-01-27 15:23 Tx date 2020-01-21	$SBM Sirona Biochem Corp.	TIAN, JIE 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$270,000 +600,000 vol $0.45 each	900,000